What does medtech — marketable security, realized gain (loss) mean?

This metric captures the net realized gains or losses resulting from the sale or disposal of marketable securities held within the medical technology business segment. It reflects the performance of the segment's investment portfolio and the tactical liquidation of financial assets. These figures are distinct from core operating income and represent non-operating financial activities.

Johnson & Johnson JNJ MedTech — Marketable Security, Realized Gain (Loss)

Similar metrics at other companies

NNMarketable security, gain (loss)

$1.2M+300%

MPAAMarketable security, gain (loss)

$48K—

MPAAMarketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments

$6.75K+238%

MPAAMarketable Securities Gain Loss Excluding Other Than Temporary Impairments

$48K—

MPAAMarketable Securities Unrealized Gain Loss

$56.25K+132%

MBOTMarketable Securities Unrealized Gain Loss

$222K—

Other financials

Income statement

See full

Revenue$24.1B+9.9%

Gross profit$16.0B+9.8%

Operating income$6.3B+2.3%

Net income$5.2B-52.4%

EPS (diluted)$2.14-52.9%

Balance sheet

See full

Cash & equivalents$21.7B-43.6%

Total debt$55.0B+5.2%

Total equity$81.2B+3.9%

Total assets$200.89B+3.7%

Cash flow

See full

Operating cash flow$2.5B-39.8%

CapEx$1.0B+31.9%

Free cash flow$1.5B-56.6%

Valuation

See full

Market cap$623.71B+66.9%

Enterprise value$657.01B+61.9%

P/E29.6×+13.2×

P/S6.5×+2.3×

Profitability

See full

Gross margin67.8%-0.5pp

Operating margin26.4%+2.8pp

Net margin21.8%-2.6pp

FCF margin18.5%-4.3pp

Returns & leverage

See full

Return on equity26.4%-3.0pp

Debt / equity0.7×0.0×

Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments.

The official record: Johnson & Johnson’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's medtech — marketable security, realized gain (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Johnson & Johnson's medtech — marketable security, realized gain (loss)?: Johnson & Johnson (JNJ) reported medtech — marketable security, realized gain (loss) of $50M in Q4 2025.
What does medtech — marketable security, realized gain (loss) mean?: This metric captures the net realized gains or losses resulting from the sale or disposal of marketable securities held within the medical technology business segment. It reflects the performance of the segment's investment portfolio and the tactical liquidation of financial assets. These figures are distinct from core operating income and represent non-operating financial activities.